Teva to discontinue mid-stage neurodegenerative disorder study
TEVA•Teva said Monday it was discontinuing its mid-stage neurodegenerative disorder study.
1. Study discontinued
Teva said it was discontinuing its mid-stage neurodegenerative disorder study.
